有没有T1c-2N0-1M0三阴性乳腺癌从新辅助化疗中获益?

Ruiliang Chen1, Yushuai Yu2, Weiwei Chen3

  • 1Department of Breast Surgery, Fujian Medical University Union Hospital, No.29, Xin Quan Road, Gulou District, Fuzhou, 350001, Fujian Province, China.

PubMed
概括

新辅助化疗 (NCT) 对早期三阴性乳腺癌 (TNBC) 的辅助化疗 (ACT) 没有显示生存益处. NCT甚至可能对T1cN0M0TNBC有害,因此在扩大其使用时需要谨慎.

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
147